Biliary Sepsis After Stent Placement With Gram-Negative Bacteremia
A 70-year-old man presents with fever, jaundice, and right upper quadrant pain for 2 days. He has cholangiocarcinoma and had a plastic biliary stent placed 3 weeks ago. Temperature is 39.0°C, blood pressure 90/60 mmHg, heart rate 120 beats/min, and respiratory rate 24 breaths/min. He is confused but has no focal neurologic deficit. Laboratory results: white blood cell count 18 × 10⁹/L, total bilirubin 6 mg/dL, alkaline phosphatase 450 U/L, ALT 120 U/L, creatinine 1.6 mg/dL, and lactate 3.5 mmol/L. Blood cultures drawn on arrival show gram-negative rods. The emergency physician starts fluids and asks about empiric antibiotics, source control, and how to interpret the cultures.
1. What empiric antibiotic regimen is appropriate, and why?
Read the worked answer
This is biliary sepsis with cholangitis, likely caused by enteric gram-negative rods, anaerobes, and possibly Enterococcus or Pseudomonas because of the indwelling stent and recent instrumentation. Start broad coverage after blood cultures: piperacillin-tazobactam 4.5 g IV every 6 hours is a reasonable first choice, with renal dose adjustment for creatinine 1.6 mg/dL. If the patient is in septic shock, has recent ESBL-producing organisms, or is otherwise high risk, meropenem 1 g IV every 8 hours is preferred. Add vancomycin only if gram-positive cocci are seen or there is significant Enterococcus risk; do not delay antibiotics for culture results. Ceftriaxone plus metronidazole would cover common Enterobacterales and anaerobes but not Pseudomonas or Enterococcus, which matters here. Fluid resuscitation, lactate monitoring, and urgent source control are equally important. The key judgement is to match coverage to the healthcare-associated biliary setting.
2. What source-control measures are needed, and when?
Read the worked answer
Source control is urgent. The infected biliary stent must be exchanged or removed, and the biliary tree drained. ERCP with stent exchange and drainage is the preferred approach; if ERCP fails or is unavailable, percutaneous transhepatic cholangiography with drainage is an alternative. Surgery is reserved for perforation, failed drainage, or other complications. Do not delay drainage for antibiotic optimization; in sepsis, source control should occur as soon as feasible, generally within 24 hours and sooner if hemodynamically unstable. Send bile cultures during the procedure. Continue antibiotics and supportive care, and monitor renal function, lactate, and blood pressure. The reasoning is that antibiotics alone cannot sterilize an obstructed, infected biliary system; drainage is definitive.
3. How should the blood culture result guide therapy, and what if it is ESBL-producing E. coli?
Read the worked answer
The gram-negative rods should be identified and tested for susceptibilities. If the isolate is a susceptible E. coli or Klebsiella, narrow to an agent such as ceftriaxone or amoxicillin-clavulanate depending on severity and source control. If it is ESBL-producing E. coli, use a carbapenem-meropenem 1 g IV every 8 hours, with renal adjustment-rather than piperacillin-tazobactam, because carbapenems are more reliable for ESBL infections. If Pseudomonas is isolated, use piperacillin-tazobactam or cefepime based on susceptibility. If Enterococcus is isolated, ampicillin may be appropriate. Reassess cultures if the patient does not improve, and consider repeat blood cultures and imaging. Duration is typically 7–14 days depending on source control and clinical response. The key is to de-escalate when possible and escalate appropriately for resistance.